Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review

Congestive heart failure is associated with increased levels of several inflammatory mediators, and animal studies have shown that infusion of a number of cytokines can induce heart failure. However, several drugs with proven efficacy in heart failure have failed to affect inflammatory mediators, an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of immunology 2015-09, Vol.82 (3), p.191-198
Hauptverfasser: Lappegård, K. T., Bjørnstad, H., Mollnes, T. E., Hovland, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 198
container_issue 3
container_start_page 191
container_title Scandinavian journal of immunology
container_volume 82
creator Lappegård, K. T.
Bjørnstad, H.
Mollnes, T. E.
Hovland, A.
description Congestive heart failure is associated with increased levels of several inflammatory mediators, and animal studies have shown that infusion of a number of cytokines can induce heart failure. However, several drugs with proven efficacy in heart failure have failed to affect inflammatory mediators, and anti‐inflammatory therapy in heart failure patients has thus far been disappointing. Hence, to what extent heart failure is caused by or responsible for the increased inflammatory burden in the patient is still unclear. Over the past couple of decades, resynchronization therapy with a biventricular pacemaker has emerged as an effective treatment in a subset of heart failure patients, reducing both morbidity and mortality. Such treatment has also been shown to affect the inflammation associated with heart failure. In this study, we review recent data on the association between heart failure and inflammation, and in particular how resynchronization therapy can affect the inflammatory process.
doi_str_mv 10.1111/sji.12328
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881750912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1881750912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4218-bc407091fcc3424041a72f00b135ad5fb71f4bd6ecc4535c3ba9b582c5515b053</originalsourceid><addsrcrecordid>eNqF0ctKAzEUBuAgiq2XhS8gATe6mHpya2bcSam2Ighe1kMmTTRlLjXpWOrTmzrqQhCzSQgff074EToiMCBxnYe5GxDKaLqF-oQNRcIgZduoDwwgybgUPbQXwhyAMCrZLurRIWQZo6yP1Nhao5e4sXik_Mwpje9NWNf6xTe1e1dL19T48cV4tVjjeJzWtlRV1d27Go-a-tmEpXszeGKUX-Ir5crWmwt8GYPenFkdoB2rymAOv_Z99HQ1fhxNktu76-no8jbRnJI0KTQHCRmxWjNOOXCiJLUABWFCzYQtJLG8mA2N1lwwoVmhskKkVAtBRAGC7aPTLnfhm9c2zpRXLmhTlqo2TRtykqZEivgC_Z9KEJJxDizSk1903rS-jh_ZKJ5KIsQwqrNOad-E4I3NF95Vyq9zAvmmojxWlH9WFO3xV2JbVGb2I787ieC8AytXmvXfSfnDzbSL_ABKeJjb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1704871556</pqid></control><display><type>article</type><title>Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review</title><source>MEDLINE</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Lappegård, K. T. ; Bjørnstad, H. ; Mollnes, T. E. ; Hovland, A.</creator><creatorcontrib>Lappegård, K. T. ; Bjørnstad, H. ; Mollnes, T. E. ; Hovland, A.</creatorcontrib><description>Congestive heart failure is associated with increased levels of several inflammatory mediators, and animal studies have shown that infusion of a number of cytokines can induce heart failure. However, several drugs with proven efficacy in heart failure have failed to affect inflammatory mediators, and anti‐inflammatory therapy in heart failure patients has thus far been disappointing. Hence, to what extent heart failure is caused by or responsible for the increased inflammatory burden in the patient is still unclear. Over the past couple of decades, resynchronization therapy with a biventricular pacemaker has emerged as an effective treatment in a subset of heart failure patients, reducing both morbidity and mortality. Such treatment has also been shown to affect the inflammation associated with heart failure. In this study, we review recent data on the association between heart failure and inflammation, and in particular how resynchronization therapy can affect the inflammatory process.</description><identifier>ISSN: 0300-9475</identifier><identifier>EISSN: 1365-3083</identifier><identifier>DOI: 10.1111/sji.12328</identifier><identifier>PMID: 26099323</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Cardiac Resynchronization Therapy - methods ; Cardiac Resynchronization Therapy Devices ; Cytokines - metabolism ; Cytokines - therapeutic use ; Heart Failure - physiopathology ; Heart Failure - therapy ; Humans ; Inflammation - therapy ; Inflammation Mediators - immunology ; Treatment Outcome</subject><ispartof>Scandinavian journal of immunology, 2015-09, Vol.82 (3), p.191-198</ispartof><rights>2015 The Foundation for the Scandinavian Journal of Immunology</rights><rights>2015 The Foundation for the Scandinavian Journal of Immunology.</rights><rights>Copyright © 2015 The Foundation for the Scandinavian Journal of Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4218-bc407091fcc3424041a72f00b135ad5fb71f4bd6ecc4535c3ba9b582c5515b053</citedby><cites>FETCH-LOGICAL-c4218-bc407091fcc3424041a72f00b135ad5fb71f4bd6ecc4535c3ba9b582c5515b053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fsji.12328$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fsji.12328$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27922,27923,45572,45573,46407,46831</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26099323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lappegård, K. T.</creatorcontrib><creatorcontrib>Bjørnstad, H.</creatorcontrib><creatorcontrib>Mollnes, T. E.</creatorcontrib><creatorcontrib>Hovland, A.</creatorcontrib><title>Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review</title><title>Scandinavian journal of immunology</title><addtitle>Scand J Immunol</addtitle><description>Congestive heart failure is associated with increased levels of several inflammatory mediators, and animal studies have shown that infusion of a number of cytokines can induce heart failure. However, several drugs with proven efficacy in heart failure have failed to affect inflammatory mediators, and anti‐inflammatory therapy in heart failure patients has thus far been disappointing. Hence, to what extent heart failure is caused by or responsible for the increased inflammatory burden in the patient is still unclear. Over the past couple of decades, resynchronization therapy with a biventricular pacemaker has emerged as an effective treatment in a subset of heart failure patients, reducing both morbidity and mortality. Such treatment has also been shown to affect the inflammation associated with heart failure. In this study, we review recent data on the association between heart failure and inflammation, and in particular how resynchronization therapy can affect the inflammatory process.</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Cardiac Resynchronization Therapy - methods</subject><subject>Cardiac Resynchronization Therapy Devices</subject><subject>Cytokines - metabolism</subject><subject>Cytokines - therapeutic use</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Failure - therapy</subject><subject>Humans</subject><subject>Inflammation - therapy</subject><subject>Inflammation Mediators - immunology</subject><subject>Treatment Outcome</subject><issn>0300-9475</issn><issn>1365-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0ctKAzEUBuAgiq2XhS8gATe6mHpya2bcSam2Ighe1kMmTTRlLjXpWOrTmzrqQhCzSQgff074EToiMCBxnYe5GxDKaLqF-oQNRcIgZduoDwwgybgUPbQXwhyAMCrZLurRIWQZo6yP1Nhao5e4sXik_Mwpje9NWNf6xTe1e1dL19T48cV4tVjjeJzWtlRV1d27Go-a-tmEpXszeGKUX-Ir5crWmwt8GYPenFkdoB2rymAOv_Z99HQ1fhxNktu76-no8jbRnJI0KTQHCRmxWjNOOXCiJLUABWFCzYQtJLG8mA2N1lwwoVmhskKkVAtBRAGC7aPTLnfhm9c2zpRXLmhTlqo2TRtykqZEivgC_Z9KEJJxDizSk1903rS-jh_ZKJ5KIsQwqrNOad-E4I3NF95Vyq9zAvmmojxWlH9WFO3xV2JbVGb2I787ieC8AytXmvXfSfnDzbSL_ABKeJjb</recordid><startdate>201509</startdate><enddate>201509</enddate><creator>Lappegård, K. T.</creator><creator>Bjørnstad, H.</creator><creator>Mollnes, T. E.</creator><creator>Hovland, A.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201509</creationdate><title>Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review</title><author>Lappegård, K. T. ; Bjørnstad, H. ; Mollnes, T. E. ; Hovland, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4218-bc407091fcc3424041a72f00b135ad5fb71f4bd6ecc4535c3ba9b582c5515b053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Cardiac Resynchronization Therapy - methods</topic><topic>Cardiac Resynchronization Therapy Devices</topic><topic>Cytokines - metabolism</topic><topic>Cytokines - therapeutic use</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Failure - therapy</topic><topic>Humans</topic><topic>Inflammation - therapy</topic><topic>Inflammation Mediators - immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lappegård, K. T.</creatorcontrib><creatorcontrib>Bjørnstad, H.</creatorcontrib><creatorcontrib>Mollnes, T. E.</creatorcontrib><creatorcontrib>Hovland, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lappegård, K. T.</au><au>Bjørnstad, H.</au><au>Mollnes, T. E.</au><au>Hovland, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review</atitle><jtitle>Scandinavian journal of immunology</jtitle><addtitle>Scand J Immunol</addtitle><date>2015-09</date><risdate>2015</risdate><volume>82</volume><issue>3</issue><spage>191</spage><epage>198</epage><pages>191-198</pages><issn>0300-9475</issn><eissn>1365-3083</eissn><abstract>Congestive heart failure is associated with increased levels of several inflammatory mediators, and animal studies have shown that infusion of a number of cytokines can induce heart failure. However, several drugs with proven efficacy in heart failure have failed to affect inflammatory mediators, and anti‐inflammatory therapy in heart failure patients has thus far been disappointing. Hence, to what extent heart failure is caused by or responsible for the increased inflammatory burden in the patient is still unclear. Over the past couple of decades, resynchronization therapy with a biventricular pacemaker has emerged as an effective treatment in a subset of heart failure patients, reducing both morbidity and mortality. Such treatment has also been shown to affect the inflammation associated with heart failure. In this study, we review recent data on the association between heart failure and inflammation, and in particular how resynchronization therapy can affect the inflammatory process.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>26099323</pmid><doi>10.1111/sji.12328</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-9475
ispartof Scandinavian journal of immunology, 2015-09, Vol.82 (3), p.191-198
issn 0300-9475
1365-3083
language eng
recordid cdi_proquest_miscellaneous_1881750912
source MEDLINE; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals
subjects Anti-Inflammatory Agents - therapeutic use
Cardiac Resynchronization Therapy - methods
Cardiac Resynchronization Therapy Devices
Cytokines - metabolism
Cytokines - therapeutic use
Heart Failure - physiopathology
Heart Failure - therapy
Humans
Inflammation - therapy
Inflammation Mediators - immunology
Treatment Outcome
title Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T12%3A42%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Cardiac%20Resynchronization%20Therapy%20on%20Inflammation%20in%20Congestive%20Heart%20Failure:%20A%20Review&rft.jtitle=Scandinavian%20journal%20of%20immunology&rft.au=Lappeg%C3%A5rd,%20K.%20T.&rft.date=2015-09&rft.volume=82&rft.issue=3&rft.spage=191&rft.epage=198&rft.pages=191-198&rft.issn=0300-9475&rft.eissn=1365-3083&rft_id=info:doi/10.1111/sji.12328&rft_dat=%3Cproquest_cross%3E1881750912%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1704871556&rft_id=info:pmid/26099323&rfr_iscdi=true